FOR PATIENTS · SOURCE READING

Immunotherapy drugs used for breast cancer

Source: Immunotherapy for Breast Cancer, National Cancer Institute.

Source updated: Not stated in this source · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

NCI patient treatment article for this disease Exact source article; not a clinically reviewed indication or current-standard recommendation.

Pembrolizumab is the only immunotherapy drug approved to treat breast cancer.

Source links and citations

Preserved source evidence · Independent clinical review pending · Not medical advice